EVERSANA

At this month's DIA Medical Affairs and Scientific Communications Forum, research conducted by experts from EVERSANA was presented on how AI-driven solutions transform Medical Information (MI) Contact Centers. The findings show AI enhances both customer experience and operational efficiency in healthcare. Key takeaways include: - Comprehensive evaluation of Contact Center as a Service (CCaaS) platforms - AI-powered tools like interactive voice response (IVR), real-time sentiment analysis & live translation - Seamless integration with MI databases, CRM systems & safety databases - Enhanced engagement for patients and healthcare professionals (HCPs) in a highly regulated environment With AI and advanced automation, pharmaceutical companies can streamline operations and improve engagement strategies like never before. Learn more: https://ow.ly/GSGt50Vhm4v Carolyn Quon Michael DeLuca, PharmD, MBA, MSRA Natalia Sánchez Gandarillas Dr. Varun Pandey, PhD

Unreliable or missing information of a patient’s insurance coverage drains time and resources from HCPs. ACTICS® eAccess solves this challenge by fully understanding a patient’s specific profile to predict their OOP down to the dollar. By elevating the entire #eBV processes, EVERSANA is helping life sciences brands accelerate therapy initiation and reduce the time and resources required to verify coverage. Schedule a meeting to learn more about the impact of ACTICS® eAccess: https://ow.ly/uyBJ50V6SEn

Are you attending World Orphan Drug Congress 2025? Don’t miss this presentation from Pierantonio Russo MD, FCPP, FAAP, STS Russo and Ramaa Nathan on groundbreaking predictive modeling techniques to identify patients with rare diseases lacking specific ICD codes in administrative claims data. Using Activated PI3K Delta Syndrome (APDS) as a case study, they will showcase how rule-based and machine learning models detected probable APDS patients and were validated against newly assigned ICD-10 codes. Discover key findings, including the model’s accuracy and potential to transform patient identification and healthcare utilization analysis. #WODC2025 #RareDiseases #PredictiveModeling Learn more: https://ow.ly/VhXq50VgMOU

At #MAPS NOLA this year, so many sessions explore the benefits of a centralized, integrated #MedicalAffairs practice. Our own team of experts – Michael DeLuca, PharmD, MBA, MSRA, Natalia Sánchez Gandarillas and Varunkumar Pandey – will be sharing their work with the poster presentation on an integrated approach: “One Team, One Voice: The Impact of Centralized Medical Content Development.” Learn more or schedule a meeting: https://ow.ly/hcBH50VgQxU MAPS Americas Date: Tuesday, March 25 Time: 4:15 p.m. CT #MedicalAffairs #IntegratedMedicalInformation

Direct-to-patient models continue to gain momentum in #pharma fueled by #AI, creating more personalized patient experiences. Scott Snyder, Chief Digital Officer at EVERSANA, shares insights on the model and what’s ahead in this interview with Pharmaceutical Executive. Read more here https://lnkd.in/gSuCVAUP

Did you know that successful first-time pharmaceutical launchers must begin preparing more than 24 months before launch? The journey to commercialization is complex and time-intensive, but with the right strategies and partnerships, you can overcome these challenges. Download our latest white paper to learn how EVERSANA's innovative partnership model can help you achieve launch success: https://ow.ly/Ch3Z50V7X4W #PharmaLaunch #LaunchPreparation #EVERSANACOMPLETE

Join #MedicalAffairs experts and panelists Mary Manna Anderson, Michael DeLuca, PharmD, MBA, MSRA and Theresa Davis at #MAPS Americas as they take the stage to discuss "Driving Medical Impact With Real-World Evidence and the Patient Voice". Moderated by Arshi Gupta. This insightful discussion will explore how integrating the patient voice with real-world evidence (RWE) empowers medical affairs to deliver data-driven insights that differentiate products and resonate in practice. https://ow.ly/G6p250VgOIQ MAPS Americas, New Orleans 🗓️ Date: Monday, March 24 🕙 Time: 10:00 – 10:45 a.m. #MedicalAffairs #RealWorldEvidence #PatientVoice #HealthcareInnovation

EVERSANA is proud to announce our participation as a Diamond Sponsor at World Orphan Drug Congress USA 2025! Join us and other top industry leaders to discuss the latest advancements in orphan drug development and commercialization as we work to enhance rare disease therapies and patient engagement. #WODC2025 #RareDiseases #OrphanDrugs Learn more: https://ow.ly/xMS750VgMy7

EVERSANA is proud to be a platinum sponsor at next week's Pharma USA 2025! We are excited to connect with fellow industry leaders, explore cutting-edge solutions, and collectively shape the future of healthcare. Will you be there? #PharmaUSA #HealthcareInnovation Learn more here: https://ow.ly/stQN50V2Uar

Join us at Asembia 2025! We're excited to connect with industry leaders and showcase our latest innovations in commercial solutions. https://ow.ly/zC5I50VgNRH Don't miss out on this opportunity to learn about how our EVERANA DIRECT Commercialization model is unique on how it transforms direct-to-patient experiences and results. See you there! Schedule a meeting https://ow.ly/lWX650VgNSO #ASX2025 #asembia2025 #HealthcareInnovation #EVERSANA